How Wegovy and Mounjaro Equivalent Doses Compare
Wegovy and Mounjaro Equivalent Doses: Understanding the Key Differences
When comparing Wegovy and Mounjaro equivalent doses, it's essential to understand these are fundamentally different medications with distinct mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This means direct dose equivalence isn't straightforward — they work through different pathways despite both supporting weight management. The dosing schedules reflect these mechanistic differences, with Wegovy's 5-step escalation designed for semaglutide's pharmacokinetics, whilst Mounjaro's 6-step programme accommodates tirzepatide's dual-receptor approach.
Both prescription-only medicines require careful dose escalation to minimise gastrointestinal side effects, but their titration schedules differ significantly. Wegovy starts at 0.25mg weekly, progressing through 0.5mg, 1mg, and 1.7mg to reach the 2.4mg maintenance dose over 16 weeks. Mounjaro begins at 2.5mg weekly, escalating every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum 15mg maintenance dose. Understanding these Wegovy and Mounjaro equivalent doses helps inform treatment selection based on individual tolerance and clinical response.
Wegovy and Mounjaro Equivalent Doses: UK Pricing Comparison
EverydayMeds offers transparent pricing for both treatments, allowing direct cost comparison at each stage. Wegovy pricing begins at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our bundles provide convenience for multiple-dose purchases, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
Mounjaro pricing follows a different structure, reflecting its distinct dosing schedule and manufacturing costs. Rather than calculating potential savings between bundle and individual purchases, our bundle pricing focuses on convenience — ensuring consistent supply without multiple orders. Both treatments represent significant investments in weight management, and your prescriber can help determine which option provides the best value for your specific clinical situation and treatment goals.
Clinical Evidence for Wegovy and Mounjaro Equivalent Doses
The STEP trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved an average of ~clinically studied weight loss at 68 weeks in the primary STEP 1 trial (Wilding et al., NEJM, 2021). The STEP 2 study showed ~clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 achieved ~16% with intensive behavioural therapy. The recent SELECT trial also demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, showing significant weight management results in its own right. However, comparing trial percentages directly between Wegovy and Mounjaro equivalent doses isn't appropriate due to different study designs, populations, and endpoints. Both medications have demonstrated efficacy in clinical trials when used alongside lifestyle interventions, and individual responses may vary based on multiple factors including genetics, adherence, and concurrent health conditions.
How Wegovy Works: The GLP-1 Mechanism Behind Dose Equivalence
Wegovy's active ingredient, semaglutide, works by mimicking GLP-1 (glucagon-like peptide-1), a natural hormone that regulates appetite and blood sugar. When administered weekly via the FlexTouch pen, semaglutide binds to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. This mechanism may also reduce food cravings and slow gastric emptying, helping patients feel satisfied with reduced caloric intake. The graduated dosing schedule from 0.25mg to 2.4mg allows the body to adapt to these effects gradually, minimising potential gastrointestinal side effects whilst building therapeutic benefit. Understanding this mechanism helps explain why Wegovy and Mounjaro equivalent doses cannot be directly compared — they work through related but distinct pathways to achieve weight management goals.
Ordering Process for Wegovy and Mounjaro Equivalent Doses
EverydayMeds streamlines access to both Wegovy and Mounjaro through our regulated UK pharmacy service (GPhC #9012878). The process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Your responses are reviewed by our qualified prescribers, with standard review completed within 3 working days or express review available within 24 hours for urgent requirements. Once approved, your prescription is dispensed and sent via next-day delivery using temperature-controlled, cold-chain packaging to maintain medication integrity. This process ensures both treatments meet the same rigorous safety standards, regardless of which option your prescriber recommends. Our pharmacy team can also provide guidance on transitioning between doses or switching treatments if clinically appropriate.
Storage and Practical Considerations for Wegovy and Mounjaro Equivalent Doses
Storage requirements represent a practical difference when comparing Wegovy and Mounjaro equivalent doses for real-world use. Both medications require refrigerated storage at 2–8°C before first use to maintain potency and safety. However, Wegovy offers superior travel flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from the fridge. Mounjaro provides only 21 days of room temperature stability, making Wegovy more suitable for extended travel or situations where refrigeration isn't consistently available. Both use pre-filled, disposable pens — Wegovy's FlexTouch system and Mounjaro's KwikPen — designed for weekly self-administration. The dose escalation schedules mean you'll typically need to store multiple pen strengths simultaneously during the initial titration period, regardless of which treatment you choose.
Wegovy and Mounjaro Equivalent Doses: Choosing Your Treatment Path
The decision between Wegovy and Mounjaro equivalent doses ultimately depends on individual factors including medical history, tolerance profile, and lifestyle considerations. Some patients may respond better to Wegovy's single-receptor GLP-1 approach, whilst others benefit from Mounjaro's dual GIP/GLP-1 mechanism. Your prescriber will consider factors such as previous medication responses, concurrent health conditions, and personal preferences when recommending treatment. Neither medication is inherently superior — they represent different therapeutic approaches to the same goal of sustainable weight management.
EverydayMeds' unique position as a supplier of both treatments means you won't need to change pharmacies if clinical circumstances require switching between medications. Our prescribers can facilitate transitions based on your individual response, ensuring continuity of care throughout your weight management journey. This flexibility, combined with our transparent pricing and reliable supply chain, provides the foundation for long-term treatment success with either option.
Start Your Weight Management Journey: Wegovy and Mounjaro Equivalent Doses Available
Both Wegovy and Mounjaro are available through EverydayMeds following clinical assessment and prescriber approval. New customers can use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing structure. Our express review service ensures rapid access when needed, whilst next-day cold-chain delivery maintains medication integrity from our GPhC-registered pharmacy to your door. The choice between Wegovy and Mounjaro equivalent doses should be made in consultation with qualified healthcare professionals who can assess your individual circumstances and treatment goals. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which treatment path may be right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
